MPE is developing a COVID-19 video series to gather information from top experts on how COVID-19 is affecting myeloma and AL amyloidosis treatment and clinical trials. Hear from experts how different countries and hospitals are managing the COVID-19 crisis:
What we do
- Member and patient community programmes
- MPE Masterclass
- Scholarship programme
- Myeloma CABs
- MPE Myeloma and AL amyloidosis Community Taskforce
- Advocate Development Programme
- European Young Myeloma Patients Group
- Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
- Research
- Access and Policy
- Educational Resources